Israel - English - Ministry of Health

mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 100 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Israel - English - Ministry of Health

mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 100 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Israel - English - Ministry of Health

mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 100 mg/vial - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Israel - English - Ministry of Health

mbi pharma ltd., israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg/vial - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

jazeera pharmaceutical industries (jpi), saudi arabia - thiotepa - lyophilisate for solution for injection - 15 mg

European Union - English - EMA (European Medicines Agency)

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastic agents - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients

Jordan - English - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

شركة أدوية الحكمة - hikma pharmaceuticals - thiotepa 15 mg - 15 mg

Israel - English - Ministry of Health

medomie pharma ltd, israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 100 mg/vial - thiotepa - indicated in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients.2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Israel - English - Ministry of Health

medomie pharma ltd, israel - thiotepa - powder for concentrate for solution for infusion - thiotepa 15 mg/vial - thiotepa - indicated in combination with other chemotherapy medicinal products:1. with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients.2. when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Israel - English - Ministry of Health

mbi pharma ltd., israel - thiotepa - powder and solvent for solution for infusion - thiotepa 400 mg - thiotepa - tepadina is indicated, in combination with other chemotherapy medicinal products:• with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic orautologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;• when high dose chemotherapy with hpct support is appropriate for the treatment of solidtumours in adult and paediatric patients.